16 hours ago
1
Soumya Eswaran
Mon, April 27, 2026 astatine 6:47 AM CDT 3 min read
Laughing Water Capital, an concern absorption company, released its first-quarter 2026 capitalist letter. A transcript of the missive tin beryllium downloaded here. The Class A concern successful Laughing Water Capital returned astir -4.5% nett of each fees and expenses successful the archetypal 4th of 2026. The SP500TR and R2000 returned -4.3% and 0.9% respectively, during the aforesaid period. Over the archetypal 10 years, since its inception, Laughing Water Capital returned astir 410%, oregon 17.7% per year. Recent developments, specified arsenic AI breakthroughs and U.S. operations successful Iran and Venezuela, show the enduring quality of planetary uncertainty. The steadfast believes volatility has generated possibilities that pb to portfolio modifications with caller additions reflecting shorter concern timelines, beardown equilibrium sheets, and near-term currency flows, with constricted lawsuit way risk. In addition, delight cheque the portfolio’s apical 5 holdings to cognize its champion picks successful 2026.
In its first-quarter 2026 capitalist letter, Laughing Water Capital highlighted Lifecore Biomedical, Inc. (NASDAQ:LFCR). Lifecore Biomedical, Inc. (NASDAQ:LFCR) is an integrated declaration improvement and manufacturing enactment engages successful the aseptic fill, and decorativeness of formulations and highly viscous sterile injectable pharmaceutical cause oregon aesculapian instrumentality products. On April 24, 2026, Lifecore Biomedical, Inc. (NASDAQ:LFCR) closed astatine $5.02 per share. One-month instrumentality of Lifecore Biomedical, Inc. (NASDAQ:LFCR) was 32.45%, and its shares mislaid 22.23% implicit the past 52 weeks. Lifecore Biomedical, Inc. (NASDAQ:LFCR) has a marketplace capitalization of $188.14 million.
Laughing Water Capital stated the pursuing regarding Lifecore Biomedical, Inc. (NASDAQ:LFCR) successful its Q1 2026 capitalist letter:
"Lifecore Biomedical, Inc. (NASDAQ:LFCR) - Lifecore, our capable decorativeness CDMO that puts drugs into syringes and vials, continues to triumph caller concern astatine an awesome rate. However, the clip from winning caller concern to generating meaningful currency flows from that concern is measured successful years successful the CDMO world. Additionally, Lifecore precocious announced that overmuch of their pipeline is moving to the close arsenic lawsuit timing has shifted. As a result, the banal has been severely punished.
The shifting timeline is of people frustrating, but I deliberation the marketplace is over-reacting to fears of a imaginable superior rise arsenic the company’s bid A convertible preferred shares mature this summer. However, these shares are designed to PIK astatine maturity if the institution is incapable to redeem them, truthful nary contiguous liquidity needs are connected the horizon. As the concern the institution has already won comes successful the door, the institution volition beryllium good positioned to woody with this and different superior operation needs…” (Click present to work the afloat text)
English (CA) · 
English (US) · 
Spanish (MX) ·